Real-world evidence for better insights

CAREONLINE pharma can play a vital role when it comes to ensuring a close but yet efficient monitoring of patients in clinical or postmarketing clinical trials. We understand that pharmaceutical companies face a major challenge when it comes to choosing patients prior to a clinical trial, the misuse of drugs or other undesired events.
PRO or RWE data simplify the process of choosing an ideal cohort of patients that are eligible for a clinical trial and thereby help lowering the risk of a reset that could cost millions.
Threshold notifications make an early detection of adverse events or drug abuse much more easier. This also helps pharamceutical companies to more efficiently manage the risk of having to reset a trials because of an overdose being taken or other adverse events.

Anamnesis Questionnaire

PRO Questionnaire

Threshold Management

Medication Plan

  • Lower costs


  • Efficient trial management


  • Risk reduction


  • Direct treatment feedback


  • Smart medication


  • Patient Compliance Management / Patient Eligibility Management


  • Identify possible comorbidities more quickly


Anamnesis Questionnaire

Anamnesis Questionnaire

Is a patient eligible to participate in a clinical trial? An appropriate anamnesis questionnaire helps pharmaceutical companies to select eligible participants for a clinical trial easily and accurately. This not only reduces the risk of having to discontinue a study due to inadequately suitable participants. The more accurate selection of participants also increases investment security for pharmaceutical companies. An efficient and accurate pre-selection of probands also makes for a reduced time-to-market and therefore contributes to significantly lowering costs for research and development departments in the pharmaceutical industry.

PRO Questionnaire

PRO Questionnaire

Using the Patient Reported Outcome (PRO) Questionnaire, the patient himself provides information on how he perceived the course of a therapy. As the PRO Questionnaire takes individual symptoms and overall well-being into account, it provides much more detailed information on therapy effects and patients' state of health. Pharmaceutical companies are using PROs as part of core outcome sets in real-world evidence (RWE) studies for clinical trials. PROs can therefore also be used for optimal and efficient selection of study participants. The highly individualized data allows even more precise selection of subjects and reduces the risk of integrating inadequately suitable participants into a study.

Threshold Management

Threshold Management

Drug abuse or adverse events present research-based pharmaceutical companies with major challenges in the context of clinical trials. With the Threshold Management feature, individual threshold values can be determined. This not only simplifies monitoring significantly thanks to automatic threshold notifications, but also significantly minimize the risk of a study being terminated. Threshold Management is furthermore a vital tool to help ensure long-term survivorship with patients involved in clinical or postmarketing trials.

Medication Plan

Medication Plan

With the Medication Plan feature, the trial monitoring team is able to send medication intake reminders and edit them if necessary. The reminder function for trial-compliant medication intake and adherence checks are essential safety functions for both the patient and the pharmaceutical company. Possible incompatibilities can be quickly checked and identified thanks to the integrated medication formulations.

More Features for CAREONLINE pharma


Electronic Health Record (EHR)

Patient Journey



Stay in touch with us

We will email you to start the conversation
Which product are you interested in?